These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35417380)

  • 1. [Deep venous thrombosis incidence in patients with COVID-19 acute respiratory distress syndrome, under intermediate dose of chemical thromboprophylaxis].
    Hunter M; Lurbet MF; Parodi J; Mandó F; Bonelli I; Rodríguez PO; López Saubidet I
    Medicina (B Aires); 2022; 82(2):181-184. PubMed ID: 35417380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and effects of deep vein thrombosis on the outcome of patients with coronavirus disease 2019 infection.
    Marini CP; Lewis E; Petrone P; Zenilman A; Lu Z; Rivera A; McNelis J
    J Vasc Surg Venous Lymphat Disord; 2022 Jul; 10(4):803-810. PubMed ID: 34775121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis.
    Santoliquido A; Porfidia A; Nesci A; De Matteis G; Marrone G; Porceddu E; Cammà G; Giarretta I; Fantoni M; Landi F; Gasbarrini A; Pola R; ; D'Alfonso ME; Lo Monaco MR
    J Thromb Haemost; 2020 Sep; 18(9):2358-2363. PubMed ID: 32633068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of deep vein thrombosis through an ultrasound surveillance protocol in patients with COVID-19 pneumonia in non-ICU setting: A multicenter prospective study.
    Pieralli F; Pomero F; Giampieri M; Marcucci R; Prisco D; Luise F; Mancini A; Milia A; Sammicheli L; Tassinari I; Caldi F; Innocenti F; Faraone A; Beltrame C; Pini R; Ungar A; Fortini A
    PLoS One; 2021; 16(5):e0251966. PubMed ID: 34015018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of deep venous thrombosis in COVID-19 critically ill patients treated with intermediate-dose of heparin for thromboprophylaxis: The COVIDOP-DVT observational study.
    Maurizot A; Chabay S; Roger G; Tapiero S; Georges JL; Flaujac C; Paul M; Roche A; Bruneel F; Ferré A
    Vascular; 2023 Apr; ():17085381231165083. PubMed ID: 37009990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of protocol-based high-intensity pharmacological thromboprophylaxis on thrombotic events in critically ill COVID-19 patients.
    Atallah B; Sadik ZG; Salem N; El Nekidy WS; Almahmeed W; Park WM; Cherfan A; Hamed F; Mallat J
    Anaesthesia; 2021 Mar; 76(3):327-335. PubMed ID: 33047335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Silent Deep Venous Thrombosis after Laparoscopic Bariatric Surgery in Patients Who Received Combined Mechanical and Chemical Thromboprophylaxis Compared to Patients Who Received Mechanical Thromboprophylaxis Only.
    Ahmad KS; Zayed ME; Faheem MH; Essa MS
    Surg Innov; 2021 Feb; 28(1):144-150. PubMed ID: 33035103
    [No Abstract]   [Full Text] [Related]  

  • 8. Rates of proximal deep vein thrombosis as assessed by compression ultrasonography in patients receiving prolonged thromboprophylaxis with low molecular weight heparin after major orthopedic surgery.
    Schellong S; Hesselschwerdt HJ; Paar WD; von Hanstein KL
    Thromb Haemost; 2005 Sep; 94(3):532-6. PubMed ID: 16268468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients.
    Singer GA; Riggi G; Karcutskie CA; Vaghaiwalla TM; Lieberman HM; Ginzburg E; Namias N; Lineen EB
    J Trauma Acute Care Surg; 2016 Dec; 81(6):1101-1108. PubMed ID: 27488490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic duplex ultrasound screening in conventional units for COVID-19 patients with follow-up of 5 days.
    Hamadé A; Jambert L; Tousch J; Talbot M; Dervieux B; El Nazer T; Bensalah N; Michel P; Lehn-Hogg M; Buschenrieder N; Obringer G; Jacquemin L; Hinschberger O; Stephan D; Woehl B
    J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):853-858. PubMed ID: 33278644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep vein thrombosis in acute respiratory distress syndrome caused by bacterial pneumonia.
    Cui N; Mi S; Jiang C; Sun W; Mao W; Zhang L; Feng X
    BMC Pulm Med; 2021 Aug; 21(1):264. PubMed ID: 34391407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of asymptomatic deep vein thrombosis in patients hospitalized with SARS-CoV-2 pneumonia: a cross-sectional study.
    Giorgi-Pierfranceschi M; Paoletti O; Pan A; De Gennaro F; Nardecchia AL; Morandini R; Dellanoce C; Lombi S; Tala M; Cancelli V; Zambelli S; Bosio G; Romanini L; Testa S
    Intern Emerg Med; 2020 Nov; 15(8):1425-1433. PubMed ID: 32840805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and Mechanical Thromboprophylaxis in Critically Ill Patients: a Network Meta-Analysis of 12 Trials.
    Park J; Lee JM; Lee JS; Cho YJ
    J Korean Med Sci; 2016 Nov; 31(11):1828-1837. PubMed ID: 27709864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enoxaparin for thromboprophylaxis after major trauma: potential cost implications.
    Shorr AF; Ramage AS
    Crit Care Med; 2001 Sep; 29(9):1659-65. PubMed ID: 11546959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective database analysis of the prevention of venous thromboembolism with low-molecular-weight heparin in acutely III medical inpatients in community practice.
    McGarry LJ; Thompson D
    Clin Ther; 2004 Mar; 26(3):419-30. PubMed ID: 15110135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors.
    Cook D; Douketis J; Meade M; Guyatt G; Zytaruk N; Granton J; Skrobik Y; Albert M; Fowler R; Hebert P; Pagliarello G; Friedrich J; Freitag A; Karachi T; Rabbat C; Heels-Ansdell D; Geerts W; Crowther M;
    Crit Care; 2008; 12(2):R32. PubMed ID: 18315876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of thromboprophylaxis using enoxaparin sodium after cesarean section: A multi-center study in Japan.
    Goto M; Yoshizato T; Tatsumura M; Takashima T; Ogawa M; Nakahara H; Satoh S; Sanui A; Eguchi F; Miyamoto S
    Taiwan J Obstet Gynecol; 2015 Jun; 54(3):248-52. PubMed ID: 26166335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
    Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
    J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors.
    Cook D; Crowther M; Meade M; Rabbat C; Griffith L; Schiff D; Geerts W; Guyatt G
    Crit Care Med; 2005 Jul; 33(7):1565-71. PubMed ID: 16003063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep vein thrombosis in noncritically ill patients with coronavirus disease 2019 pneumonia: deep vein thrombosis in nonintensive care unit patients.
    Jimenez-Guiu X; Huici-Sánchez M; Rmera-Villegas A; Izquierdo-Miranda A; Sancho-Cerro A; Vila-Coll R
    J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):592-596. PubMed ID: 32911110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.